CHASE INVESTMENT COUNSEL CORP

Position in INDV — Indivior Pharmaceuticals, Inc.

CIK 19475 CHARLOTTESVILLE, VA

Position in INDV

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$5,322,986

New position

Shares Held

129,734

first reported quarter

Ownership

0.110%

of shares outstanding

% of Portfolio

1.13%

of 13F equity value

Holder Rank

#83

of 334 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHASE INVESTMENT COUNSEL CORP holds $10,003,660 across 4 Drug Manufacturers - Specialty & Generic names. INDV ranks #1 (53.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INDV	Indivior Pharmaceuticals, Inc. This page	129,734	$5,322,986
2	LNTH	Lantheus Holdings, Inc.	20,000	$2,218,800
3	UTHR	UNITED THERAPEUTICS Corp	4,000	$2,167,320
4	ZTS	Zoetis Inc.	4,099	$294,554

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,322,986	129,734	—	Shares	Sole	2026-08-06
No filing history on record for this holder in this stock.